P00811 (AMPC_ECOLI) Escherichia coli (strain K12)

Beta-lactamase UniProtKBInterProSTRINGInteractive Modelling

377 aa; Sequence (Fasta) ; 2 identical sequences: Escherichia coli H386: A0A1X3J8J8; Escherichia coli: A0A138LII1

Available Structures

115 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of AmpC beta-lactamase in complex with covalently bound N-formyl 7-aminocephalosp…homo-2-mer20-377
2TV;PO4;
Assess
X-ray crystal structure of the extended-spectrum AmpC E219K mutant beta-lactamase at 1.84 Angstrom …homo-2-mer20-377
PO4;
Assess
AmpC beta-lactamase in complex with a p.carboxyphenylboronic acidhomo-2-mer20-377
C9P;
Assess
AmpC beta-lactamase in complex with 5-diformylaminomethyl-benzo[b]thiophen-2-boronic acidhomo-2-mer20-377
VA1;
Assess
AMPC BETA-LACTAMASE FROM E. COLI COMPLEXED WITH INHIBITOR, BENZO(B)THIOPHENE-2-BORONIC ACID (BZB)homo-2-mer20-377
BZB;
Assess
AMPC BETA-LACTAMASE FROM E. COLI COMPLEXED WITH INHIBITOR CLOXACILLINBORONIC ACIDhomo-2-mer20-376
PO4;105;
Assess
AMPC BETA-LACTAMASE FROM E. COLI COMPLEXED WITH INHIBITOR CEPHALOTHINBORONIC ACIDhomo-2-mer20-376
PO4;CTB;
Assess
AMPC BETA-LACTAMASE FROM ESCHERICHIA COLIhomo-2-mer20-376
Assess
Class C beta-lactamase from Escherichia colimonomer19-377
EDO;
Assess
class C beta-lactamase from Escherichia coli in complex with cephalothinmonomer19-377
EDO;9EP;
Assess
AmpC beta-lactamase N289A mutant in complex with a boronic acid deacylation transition state analog…monomer20-377
K;SM3;
Assess
AmpC beta-lactamase in complex with 4-Methanesulfonylamino benzoic acidmonomer20-377
GLC;PO4;4MB;
Assess
Crystal structure of AmpC from E.coli with Zidebactam (WCK 5107)monomer20-377
PEG;C8V;ZN;CL;
Assess
Crystal structure of AmpC beta-lactamase in complex with fragment 5 (N-{[3-(2-chlorophenyl)-5-methy…monomer20-377
1U3;PO4;
Assess
Crystal structure of AmpC beta-lactamase in complex with the product form of 7-amino-desacetoxyceph…monomer20-377
PO4;
Assess
Crystal structure of AmpC beta-lactamase in complex with fragment 50 (N-(methylsulfonyl)-N-phenyl-a…monomer20-377
NZ2;NZ3;
Assess
Structure of N289A mutant of AmpC in complex with SM3, a phenylglyclboronic acid bearing the cephal…monomer20-377
PO4;K;SM3;
Assess
Crystal structure of AmpC from E. coli with Taniborbactam (VNRX-5133)monomer20-377
KJK;MES;PEG;EDO;K9K;ZN;CL;NA;
Assess
AmpC beta-lactamase in complex with (3,5-di-tert-butylphenyl) boronic acidmonomer20-377
25N;PO4;
Assess
Crystal structure of AmpC beta-lactamase in complex with fragment 60 (2-[(propylsulfonyl)amino]benz…monomer20-377
PO4;
Assess
Crystal structure of AmpC beta-lactamase in complex with a designed 4-tetrazolyl pyridine sulfonami…monomer20-377
0NA;PO4;
Assess
Crystal structure of AmpC beta-lactamase in complex with fragment 16 ((1R,4S)-4,7,7-trimethyl-3-oxo…monomer20-377
1U5;PO4;
Assess
Crystal structure of AmpC beta-lactamase in complex with a 3-chloro-4-tetrazolyl benzene sulfonamid…monomer20-377
0NB;PO4;
Assess
Crystal structure of AmpC beta-lactamase in complex with a 2-chloro-4-tetrazolyl benzene sulfonamid…monomer20-377
0ND;
Assess
Crystal structure of AmpC from E.coli with Nacubactam (OP0595)monomer20-377
MES;OP0;ZN;SO4;PGE;CL;
Assess
Crystal structure of AmpC beta-lactamase in complex with the product form of (6R,7R)-7-amino-8-oxo-…monomer20-377
2UZ;PO4;
Assess
Structure of N289A mutant of AmpC in complex with SM2, carboxyphenylglycylboronic acid bearing the …monomer20-377
PO4;K;SM2;
Assess
AmpC beta-lactamase in complex with 2-acetamidothiophene-3-carboxylic acidmonomer20-377
F12;
Assess
Crystal structure of AmpC beta-lactamase in complex with a 2-trifluoromethyl-4-tetrazolyl benzene s…monomer20-377
0NE;PO4;
Assess
AmpC K67R mutant apo structuremonomer20-377
PO4;
Assess
X-ray crystal structure of AmpC beta-lactamase with inhibitormonomer20-377
H7D;
Assess
X-ray Crystal Structure of AmpC S64G Mutant beta-Lactamasemonomer20-377
GLC;PO4;
Assess
Crystal structure of AmpC from E.colimonomer20-377
EDO;ZN;SO4;CL;
Assess
Crystal structure of AmpC from E.coli with Avibactammonomer20-377
PGE;NXL;ZN;CL;
Assess
X-ray Crystal Structure of AmpC S64D Mutant beta-Lactamasemonomer20-377
PO4;
Assess
X-ray Crystal Structure of AmpC S64G Mutant beta-Lactamase in Complex with Substrate and Product Fo…monomer20-377
PO4;KCP;CLS;
Assess
Crystal structure of AmpC beta-lactamase in complex with fragment 48 (3-(cyclopropylsulfamoyl)thiop…monomer20-377
NZ9;PO4;
Assess
Crystal structure of AmpC beta-lactamase in complex with a small chloromethyl sulfonamide boronic a…monomer20-377
0NG;PO4;
Assess
Crystal structure of AmpC beta-lactamase in complex with a sulfonamide boronic acid inhibitormonomer20-377
BSF;PO4;
Assess
Crystal structure of AmpC beta-lactamase in complex with a designed 3-carboxyl benzyl sulfonamide b…monomer20-377
0N3;PO4;
Assess
Crystal structure of AmpC from E. coli with Cyclic Boronate 3 (CB3 / APC308)monomer20-377
KL8;PEG;DMS;EDO;CL;ZN;
Assess
X-ray crystal structure of the extended-spectrum AmpC E219K mutant beta-lactamase complexed with be…monomer20-377
PO4;BZB;
Assess
Crystal structure of AmpC beta-lactamase in complex with a sulfonamide boronic acid inhibitormonomer20-377
BSH;PO4;
Assess
X-ray crystal structure of the extended-spectrum AmpC omega loop insertion (H210AAA) mutant beta-la…monomer20-377
PO4;
Assess
AmpC beta-lactamase in complex with [1-(6-chloropyrimidin-4-yl)-1H-pyrazol-4-yl] boronic acidmonomer20-377
N95;PO4;
Assess
Crystal Structure of AmpC beta-lactamase from E. coli in Complex with Oxacillinmonomer20-377
1S6;PO4;
Assess
AmpC beta-lactamase in complex with m-aminophenyl boronic acidmonomer20-377
APB;PO4;
Assess
X-ray Crystal Structure of AmpC N152H Mutant beta-Lactamasemonomer20-377
PO4;
Assess
Crystal structure of AmpC beta-lactamase in complex with fragment 44 (5-chloro-3-sulfamoylthiophene…monomer20-377
1U1;PO4;
Assess
Crystal structure of AmpC beta-lactamase in complex with fragment 13 ((2R,6R)-6-methyl-1-(3-sulfany…monomer20-377
PO4;
Assess
Crystal Structure of the complex between Q120L/Y150E mutant of AmpC and a beta-lactam inhibitor (MX…monomer20-377
K;MXG;
Assess
AmpC beta-lactamase in complex with an M.carboxyphenylglycylboronic acid bearing the cephalothin R1…monomer20-377
PO4;SM3;
Assess
Crystal Structure Of AmpC beta-Lactamase From E. Coli In Complex With ATMO-penicillinmonomer20-377
Assess
X-ray crystal structure of AmpC beta-lactamase from E. colimonomer20-377
PO4;
Assess
Crystal structure of AmpC from E.coli with Relebactam (MK-7655)monomer20-377
PEG;MK7;ZN;MES;SO4;CL;
Assess
Crystal structure of AmpC beta-lactamase in complex with fragment 41 ((4R,4aS,8aS)-4-phenyldecahydr…monomer20-377
PO4;1U7;
Assess
AmpC beta-lactamase in complex with [1-(3-chlorophenyl)-1H-pyrazol-4-yl] boronic acidmonomer20-377
NL9;PO4;
Assess
Crystal Structure of AmpC beta-lactamase N152G Mutant from E. colimonomer20-377
PO4;
Assess
Crystal structure of AmpC from E.coli with Enmetazobactam (AAI-101)monomer20-377
SO4;PEG;M9W;ZN;CL;
Assess
X-ray crystal structure of AmpC beta-lactamase from E. coli in complex with a non-covalent inhibito…monomer20-377
1MU;PO4;
Assess
Crystal structure of AmpC beta-lactamase in complex with a sulfonamide boronic acid inhibitormonomer20-377
BSG;PO4;
Assess
X-ray crystal structure of AmpC beta-lactamase with nanomolar inhibitormonomer20-377
H7M;
Assess
Crystal structure of AmpC beta-lactamase in complex with a designed 4-tetrazolyl benzene sulfonamid…monomer20-377
0N4;PO4;
Assess
X-ray crystal structure of AmpC WT beta-lactamase in complex with covalently bound imipenemmonomer20-377
IM2;
Assess
AmpC beta-lactamase in complex with Fragment-based Inhibitormonomer20-377
PO4;3GV;DMS;
Assess
AmpC beta-lactamase in complex with Fragment-based Inhibitormonomer20-377
DMS;GF7;
Assess
AmpC beta-lactamase with bound Phthalamide inhibitormonomer20-377
PO4;23C;
Assess
AmpC beta-lactamase in complex with Fragment-based Inhibitormonomer20-377
GF4;
Assess
Structure of AmpC beta-lactamase with cross-linked active site after exposure to small molecule inh…monomer20-377
Assess
AmpC beta-lactamase in complex with Fragment-based Inhibitormonomer20-377
GV9;PO4;PEG;
Assess
CRYSTAL STRUCTURE OF THE E. COLI AMPC BETA-LACTAMASE MUTANT N152A COVALENTLY ACYLATED WITH THE INHI…monomer20-377
MOX;
Assess
AmpC beta-lactamase in complex with an m.carboxyphenylglycylboronic acid bearing the cephalothin R1…monomer20-377
PO4;SM2;
Assess
AmpC K67R mutant complexed with benzo(b)thiophene-2-boronic acid (bzb)monomer20-377
BZB;PO4;
Assess
AmpC beta-lactamase with bound Phthalamide inhibitormonomer20-377
PO4;DK2;
Assess
Crystal Structure Of AmpC beta-Lactamase From E. Coli In Complex With Amoxicillinmonomer20-377
Assess
Crystal Structure of AmpC beta-lactamase from E. coli in Complex with Cefotaximemonomer20-377
PO4;CEF;
Assess
Crystal Structure of AmpC beta-lactamase N152G Mutant in Complex with Cefoxitinmonomer20-377
PO4;1S7;
Assess
X-ray crystal structure of AmpC beta-lactamase with inhibitormonomer20-377
H7G;
Assess
X-ray crystal structure of AmpC beta-lactamase from E. coli in complex with a non-covalent inhibito…monomer20-377
PO4;
Assess
AmpC beta-lactamase in complex with Fragment-based Inhibitormonomer20-377
PO4;GTC;
Assess
The crystal structure of a Beta-lactamase from Escherichia coli CFT073monomer20-377
GOL;SO4;
Assess
X-ray crystal structure of the extended-spectrum AmpC Y221G mutant beta-lactamase at 1.90 Angstrom …monomer20-377
GLC;PO4;
Assess
AmpC beta-lactamase with bound Phthalamide inhibitormonomer20-377
PO4;WH6;DMS;
Assess
X-ray Crystal Structure of AmpC K67Q Mutant beta-Lactamasemonomer20-377
PO4;
Assess
X-ray crystal structure of AmpC beta-lactamase with inhibitormonomer20-377
H7A;
Assess
X-ray crystal structure of AmpC beta-lactamase from E. coli in complex with a DOCK-predicted non-co…monomer20-377
STC;
Assess
AmpC beta-lactamase in complex with 3-(3-nitro-phenylsulfamoyl)-thiophene-2-carboxylic acidmonomer20-377
Assess
AmpC beta-lactamase in complex with 3-(4-carboxy-2-hydroxy-phenylsulfamoyl)-thiophene-2-carboxylic …monomer20-377
HTC;
Assess
AmpC beta-lacamase with bound covalent oxadiazole inhibitormonomer20-377
DMS;OX6;
Assess
Crystal Structure of AmpC beta-lactamase from E. coli in Complex with Ceftazidimemonomer20-377
PO4;CAZ;
Assess
AmpC Beta-lactamase in complex with (1R)-1-(2-Thiophen-2-yl-acetylamino)-1-(3-(2-carboxyvinyl)-phen…monomer20-377
SM4;PO4;
Assess
Crystal structure of AmpC from E. coli with cyclic boronate 2monomer20-377
OK3;MPD;EPE;NA;CL;
Assess
X-ray Crystal Structure of AmpC WT beta-Lactamase in Complex with Covalently Bound Cephalothinmonomer20-377
PO4;
Assess
AmpC beta-lactamase in complex with 2-carboxythiophenemonomer20-377
C21;
Assess
CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI COMPLEXED WITH NON-BETA-LACTAMASE INHIBITOR (…monomer20-377
PO4;ETP;
Assess
AmpC beta-lactamase in complex with Fragment-based Inhibitormonomer20-377
PO4;DMS;GF1;
Assess
Crystal Structure of AmpC beta-lactamase N152G Mutant in Complex with Cefotaximemonomer20-377
PO4;CEF;
Assess
X-ray crystal structure of the extended-spectrum AmpC T70I mutant beta-lactamase with and without b…monomer20-377
Assess
X-ray crystal structure of AmpC beta-lactamase from E. coli in complex with the inhibitor 3-nitroph…monomer20-377
NPB;
Assess
X-ray crystal structure of AmpC beta-lactamase from E. coli in complex with the inhibitor 4,4'-biph…monomer20-377
PO4;BDB;
Assess
CRYSTAL STRUCTURE OF THE E. COLI AMPC BETA-LACTAMASE COVALENTLY ACYLATED WITH THE INHIBITORY BETA-L…monomer20-377
MOX;
Assess
AmpC beta-lactamase in complex with 4-Amino-3-hydroxybenzoic acidmonomer20-377
PO4;4A3;
Assess
X-ray crystal structure of AmpC beta-lactamase from E. coli in complex with the inhibitor 4-carboxy…monomer20-377
PO4;4CB;
Assess
Crystal structure of AmpC beta-lactamase in complex with fragment 20 (1,3-diethyl-2-thioxodihydropy…monomer20-377
1U6;PO4;
Assess
X-ray crystal structure of AmpC beta-lactamase from E. coli in complex with a non-covalent inhibito…monomer20-377
1MW;PO4;
Assess
X-ray crystal structure of AmpC beta-lactamase from E. coli in complex with the inhibitor 4-(carbox…monomer20-377
PO4;CVB;
Assess
X-ray crystal structure of the extended-spectrum AmpC Y221G mutant beta-lactamase in complex with c…monomer20-377
Assess
Crystal Structure of AmpC beta-lactamase from E. coli in Complex with a Boronic Acid Inhibitor (1, …monomer20-377
PO4;CB4;
Assess
Crystal Structure of the E. Coli AMPC Beta-Lactamase Mutant Q120L/Y150E Covalently Acylated with th…monomer20-377
LOR;
Assess
CRYSTAL STRUCTURE OF THE E.COLI AMPC BETA-LACTAMASE MUTANT Q120L/Y150E COVALENTLY ACYLATED WITH THE…monomer20-377
CXU;
Assess
AmpC beta-lactamase in complex with Fragment-based Inhibitormonomer20-377
PO4;G14;PEG;
Assess
X-ray crystal structure of the extended-spectrum AmpC V298E mutant beta-lactamase at 2.64 Angstrom …monomer20-377
SO4;
Assess
Crystal structure of the S61A mutant of AmpC BERmonomer21-377
CIT;
Assess
AMPC BETA-LACTAMASE FROM ESCHERICHIA COLImonomer20-376
APB;
Assess
Class C beta-lactamase from Escherichia coli in complex with Tazobactammonomer21-377
TBE;EDO;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1my8.1.Amonomer0.9120-377
100.00
Assess